Skip to content

Catalyst Pharmaceutical CPRX Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin86%-0.2pp85.2%-0.8pp85.7%-0.6pp85.8%-0.9pp86.1%-0.6pp
Operating margin44.8%+1.6pp43.8%+4.1pp44.8%+7.0pp43.6%+23.8pp43.3%+24.2pp
Net margin37.1%+0.2pp36.4%+3.1pp37.6%+6.6pp37.4%+21.7pp36.9%+21.1pp
Returns
Return on equity24.5%-4.6pp25.5%-3.9pp27.5%-0.8pp28.5%+14.6pp29.1%+14.6pp
Return on invested capital83.9%+8.9pp84.5%+21.2pp86.6%+28.5pp84.4%+55.7pp75%+48.3pp
Efficiency
Asset turnover0.6×-0.1×0.6×-0.1×0.6×-0.1×0.7×-0.1×0.7×-0.1×
Liquidity
Current ratio7.1×+1.0×6.1×+0.9×6.6×+1.5×6.7×+1.6×6.1×+1.1×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Net debt / EBITDA-2.5×-0.3×-2.4×-0.2×-2.3×-0.2×-2.3×+0.7×-2.1×+0.5×
Per Share
Book value per share$7.98+27.6%$7.50+28.8%$7.24+37.4%$6.71+37.5%$6.26+37.5%
Valuation
Market capitalization$3.02B+2.7%$2.87B+15.2%$2.41B+2.2%$2.69B+47.1%$2.95B+56.8%
Price / earnings13.7×-1.3×13.4×-1.8×11.1×-5.4×12.9×-13.9×14.9×-13.9×
Price / sales5.1×-0.4×4.9×-0.2×4.2×-1.0×4.8×+0.6×5.5×+0.9×
Price / book-0.7×-0.4×2.6×-0.9×3.1×+0.1×3.7×+0.4×
EV / EBITDA7.4×-1.4×7.3×-1.2×5.8×-3.3×7.3×-4.6×8.8×-5.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Catalyst Pharmaceutical's profit margins?
Catalyst Pharmaceutical (CPRX) runs a 86.0% gross margin and a 44.8% operating margin, with a 37.1% net margin.
Where do Catalyst Pharmaceutical's ratios come from?
Every ratio is computed from Catalyst Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.